Literature DB >> 30664671

Clinical studies on low intensity extracorporeal shockwave therapy for erectile dysfunction: a systematic review and meta-analysis of randomised controlled trials.

Ioannis Sokolakis1, Georgios Hatzichristodoulou2.   

Abstract

The efficacy of low intensity extracorporeal shock wave therapy (LI-ESWT) for erectile dysfunction (ED) has received hard criticism and recently published meta-analyses were not able to provide further insights, nor specific recommendations. The aim of this systematic review and meta-analysis is to evaluate the efficacy of LI-ESWT for ED, identify the ideal treatment population and treatment protocol, and provide recommendations for future research in the field. A systematic research for relevant clinical studies published from January 2010 to September 2018 was performed, using the following databases: Medline, Embase, The Cochrane Library, Scopus, and Web of Science. Only clinical studies that investigated the efficacy of LI-ESWT for ED only, and reported primary outcomes using IIEF-EF scores/questionnaires were included. Both, randomised controlled trials (RCTs) and cohort studies were included, but the meta-analysis was performed only for sham-controlled RCTs. Ten RCTs including 873 patients were selected for the meta-analysis. Pooling data of these studies showed that LI-ESWT could significantly improve erectile function in men with ED regarding both patient-subjective outcomes (IIEF-EF: +3.97; 95% CI [2.09-5.84]; p < 0.0001, EHS ≥ 3: OR: 4.35; 95% CI [1.82-10.37]; p = 0.0009) and patient-objective outcomes (peak systolic velocity: +4.12; 95% CI [2.30-5.94]; p < 0.00001). In conclusion, the present meta-analysis provided results showing that LI-ESWT significantly improves erectile function in patients with vasculogenic ED.

Entities:  

Year:  2019        PMID: 30664671     DOI: 10.1038/s41443-019-0117-z

Source DB:  PubMed          Journal:  Int J Impot Res        ISSN: 0955-9930            Impact factor:   2.896


  22 in total

Review 1.  Alternative Treatment for Erectile Dysfunction: a Growing Arsenal in Men's Health.

Authors:  Wade Muncey; Nicholas Sellke; Tyler Kim; Kirtishri Mishra; Nannan Thirumavalavan; Aram Loeb
Journal:  Curr Urol Rep       Date:  2021-01-09       Impact factor: 3.092

2.  Response to Comment on 'Comparison of the efficacy of the early LI-SWT plus daily tadalafil with daily tadalafil only as penile rehabilitation for postprostatectomy erectile dysfunction'.

Authors:  Jae-Wook Chung; Tae Gyun Kwon; Se Won Jang
Journal:  Int J Impot Res       Date:  2022-07-07       Impact factor: 2.896

Review 3.  News and future perspectives of non-surgical treatments for erectile dysfunction.

Authors:  Celeste Manfredi; Fabio Castiglione; Mikkel Fode; Michal Lew-Starowicz; Javier Romero-Otero; Carlo Bettocchi; Giovanni Corona
Journal:  Int J Impot Res       Date:  2022-07-27       Impact factor: 2.408

Review 4.  Clinical application of the therapeutic ultrasound in urologic disease: Part II of therapeutic ultrasound in urology.

Authors:  Minh-Tung Do; Tam Hoai Ly; Min Joo Choi; Sung Yong Cho
Journal:  Investig Clin Urol       Date:  2022-05-16

Review 5.  Understanding cavitation-related mechanism of therapeutic ultrasound in the field of urology: Part I of therapeutic ultrasound in urology.

Authors:  Sung Yong Cho; Ohbin Kwon; Seong-Chan Kim; Hyunjae Song; Kanghae Kim; Min Joo Choi
Journal:  Investig Clin Urol       Date:  2022-05-26

6.  Comparison of the efficacy of the early LI-SWT plus daily tadalafil with daily tadalafil only as penile rehabilitation for postprostatectomy erectile dysfunction.

Authors:  Jae-Wook Chung; Tae Gyun Kwon; Se Won Jang; Eun Hye Lee; So Young Chun; Yun-Sok Ha; Seock Hwan Choi; Jun Nyung Lee; Bum Soo Kim; Hyun Tae Kim; See Hyung Kim; Tae-Hwan Kim; Eun Sang Yoo
Journal:  Int J Impot Res       Date:  2022-03-28       Impact factor: 2.408

Review 7.  Restorative Therapies for Erectile Dysfunction: Position Statement From the Sexual Medicine Society of North America (SMSNA).

Authors:  James L Liu; Kevin Y Chu; Andrew T Gabrielson; Run Wang; Landon Trost; Gregory Broderick; Kelvin Davies; Gerald Brock; John Mulhall; Ranjith Ramasamy; Trinity J Bivalacqua
Journal:  Sex Med       Date:  2021-05-14       Impact factor: 2.491

8.  Low-Intensity Extracorporeal Shock Wave Therapy Ameliorates the Overactive Bladder: A Prospective Pilot Study.

Authors:  Yung-Chin Lee; Shu-Mien Chuang; Kun-Ling Lin; Wei-Chiao Chen; Jian-He Lu; Kuang-Shun Chueh; Mei-Chen Shen; Li-Wen Liu; Cheng-Yu Long; Yung-Shun Juan
Journal:  Biomed Res Int       Date:  2020-07-06       Impact factor: 3.411

9.  Extracorporeal shock wave therapy in the supportive care and rehabilitation of cancer patients.

Authors:  Richard Crevenna; Michael Mickel; Mohammad Keilani
Journal:  Support Care Cancer       Date:  2019-08-24       Impact factor: 3.603

Review 10.  Low-intensity shock wave therapy for the treatment of vasculogenic erectile dysfunction: a narrative review of technical considerations and treatment outcomes.

Authors:  Pedro Simoes de Oliveira; Matthew J Ziegelmann
Journal:  Transl Androl Urol       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.